In its rush to overturn as much of former president Trump’s legacy as possible, the Biden administration has issued an executive order freezing an executive order by Trump that would have had the effect of lowering the price of insulin for many people.
The Trump executive order, which was set to take effect on January 22, 2021, would have required all Federally Qualified Health Centers to offer the discounted price they receive on insulin. However, the Biden administration implemented a freeze on all Trump regulatory orders on its first day in office, putting the order lowering insulin prices for certain patients on hold.
In response to the Biden administration’s actions, Texas State Senator Lois Kolkhorst (R-Brenham) has filed a bill to cap the price of insulin at $50.
“As chair of the Senate Committee on Health & Human Services, I was alarmed when the Biden Administration froze the Trump Administrations cap for some Medicare and Medicare Advantage plans,” said Kolkhorst.
“That’s why I have taken action and filed SB 827 with the support of a broad bipartisan coalition of lawmakers to see that no Texan has to choose between paying for food or insulin!”
Kolkorst stated that approximately 3 million Texans, or 11 percent of the state’s population, live with diabetes in some form. Many of these people’s lives depend on insulin, and many have a hard time affording the cost.
“This is a matter of life and death and for many Texans,” said Kolkhorst, “rising insulin prices have forced them to the breaking point.”